$BIGC
BigCommerce Holdings, Inc.

2021 Q1 Form 10-Q Financial Statement

#000156459021026757 Filed on May 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $46.66M $33.17M
YoY Change 40.65% 29.67%
Cost Of Revenue $9.250M $7.480M
YoY Change 23.66% 26.24%
Gross Profit $37.41M $25.69M
YoY Change 45.6% 30.7%
Gross Profit Margin 80.18% 77.45%
Selling, General & Admin $32.42M $22.23M
YoY Change 45.84% 16.16%
% of Gross Profit 86.65% 86.51%
Research & Development $13.54M $10.92M
YoY Change 23.94% 0.82%
% of Gross Profit 36.18% 42.5%
Depreciation & Amortization $700.0K $900.0K
YoY Change -22.22% 69.81%
% of Gross Profit 1.87% 3.5%
Operating Expenses $45.95M $33.15M
YoY Change 38.62% 10.62%
Operating Profit -$8.542M -$7.455M
YoY Change 14.58% -27.68%
Interest Expense $10.00K $762.0K
YoY Change -98.69% 111.67%
% of Operating Profit
Other Income/Expense, Net -$14.00K -$203.0K
YoY Change -93.1% 866.67%
Pretax Income -$8.544M -$4.006M
YoY Change 113.28% -61.97%
Income Tax $0.00 $17.00K
% Of Pretax Income
Net Earnings -$8.544M -$4.023M
YoY Change 112.38% -61.83%
Net Earnings / Revenue -18.31% -12.13%
Basic Earnings Per Share
Diluted Earnings Per Share -$122.4K -$61.06K
COMMON SHARES
Basic Shares Outstanding 68.53M
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $208.0M $33.00M
YoY Change 530.3%
Cash & Equivalents $189.6M $33.03M
Short-Term Investments $18.40M $0.00
Other Short-Term Assets $11.30M $9.500M
YoY Change 18.95%
Inventory
Prepaid Expenses
Receivables $26.10M $16.10M
Other Receivables $0.00 $0.00
Total Short-Term Assets $245.4M $58.60M
YoY Change 318.77%
LONG-TERM ASSETS
Property, Plant & Equipment $18.10M $21.20M
YoY Change -14.62%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $5.400M $2.200M
YoY Change 145.45%
Total Long-Term Assets $23.40M $23.40M
YoY Change 0.0%
TOTAL ASSETS
Total Short-Term Assets $245.4M $58.60M
Total Long-Term Assets $23.40M $23.40M
Total Assets $268.8M $82.00M
YoY Change 227.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.700M $6.000M
YoY Change -21.67%
Accrued Expenses $18.20M $11.30M
YoY Change 61.06%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $2.200M
YoY Change
Total Short-Term Liabilities $40.10M $33.10M
YoY Change 21.15%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $69.50M
YoY Change -100.0%
Other Long-Term Liabilities $13.40M $15.70M
YoY Change -14.65%
Total Long-Term Liabilities $13.40M $85.20M
YoY Change -84.27%
TOTAL LIABILITIES
Total Short-Term Liabilities $40.10M $33.10M
Total Long-Term Liabilities $13.40M $85.20M
Total Liabilities $53.50M $118.3M
YoY Change -54.78%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $215.3M -$261.7M
YoY Change
Total Liabilities & Shareholders Equity $268.8M $82.00M
YoY Change 227.8%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income -$8.544M -$4.023M
YoY Change 112.38% -61.83%
Depreciation, Depletion And Amortization $700.0K $900.0K
YoY Change -22.22% 69.81%
Cash From Operating Activities -$12.76M -$9.990M
YoY Change 27.71% -10.24%
INVESTING ACTIVITIES
Capital Expenditures -$480.0K -$600.0K
YoY Change -20.0% -50.0%
Acquisitions
YoY Change
Other Investing Activities -$18.37M $0.00
YoY Change -100.0%
Cash From Investing Activities -$18.85M -$597.0K
YoY Change 3058.12% -105.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.741M 35.55M
YoY Change -95.1% 951.75%
NET CHANGE
Cash From Operating Activities -12.76M -9.990M
Cash From Investing Activities -18.85M -597.0K
Cash From Financing Activities 1.741M 35.55M
Net Change In Cash -29.87M 24.96M
YoY Change -219.67% 670.43%
FREE CASH FLOW
Cash From Operating Activities -$12.76M -$9.990M
Capital Expenditures -$480.0K -$600.0K
Free Cash Flow -$12.28M -$9.390M
YoY Change 30.76% -5.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
18374000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12672000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
22894000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8000000
CY2020Q4 bigc Deferred Commissions Current
DeferredCommissionsCurrent
2571000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
254072000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7122000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11842000
CY2020Q4 us-gaap Liabilities
Liabilities
59867000
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5171000
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8544000
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5768000
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.31
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
69792000
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
18645000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8544000
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
9250000
CY2021Q1 us-gaap Gross Profit
GrossProfit
37410000
CY2020Q1 us-gaap Gross Profit
GrossProfit
25694000
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
20809000
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15762000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13535000
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10921000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11608000
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6466000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
45952000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
33149000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-8542000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7455000
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
12000
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000
CY2020Q1 us-gaap Interest Expense
InterestExpense
762000
CY2020Q1 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
4413000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-14000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-203000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8544000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4006000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-8544000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-4023000
CY2020Q1 bigc Dividends And Accretion Of Issuance Costs
DividendsAndAccretionOfIssuanceCosts
1745000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4023000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-257303000
CY2020Q1 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
bigc:AccountingStandardsUpdate202006Member
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
404000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1026000
CY2020Q1 bigc Changes In Preferred Stock Dividends
ChangesInPreferredStockDividends
1727000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
18000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
297000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-261708000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1952000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-8544000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-4023000
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
706000
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
907000
CY2020Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
118000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5171000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1026000
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
726000
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
589000
CY2020Q1 us-gaap Increase Decrease In Financial Instruments Used In Operating Activities
IncreaseDecreaseInFinancialInstrumentsUsedInOperatingActivities
4413000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1130000
CY2021Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
18374000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18854000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-597000
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1741000
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
404000
CY2020Q1 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
40745000
CY2020Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
5600000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1741000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
35549000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-29871000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
24962000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
220607000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9150000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
190736000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
34112000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
601000
CY2020Q1 bigc Noncash Transaction Warrants Issued In Connection With Debt
NoncashTransactionWarrantsIssuedInConnectionWithDebt
297000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33026000
CY2020Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
1086000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3899000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1466000
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
582000
CY2020Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1097000
CY2021Q1 bigc Increase Decrease In Deferred Commissions
IncreaseDecreaseInDeferredCommissions
796000
CY2020Q1 bigc Increase Decrease In Deferred Commissions
IncreaseDecreaseInDeferredCommissions
182000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2146000
CY2021Q1 bigc Increase Decrease In Accrued And Other Current Liabilities
IncreaseDecreaseInAccruedAndOtherCurrentLiabilities
-6399000
CY2020Q1 bigc Increase Decrease In Accrued And Other Current Liabilities
IncreaseDecreaseInAccruedAndOtherCurrentLiabilities
-3259000
CY2021Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1989000
CY2020Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-336000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12758000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9990000
CY2021Q1 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
480000
CY2020Q1 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
597000
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with GAAP requires certain financial instruments to be recorded at fair value; requires our management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenue and expenses during the reporting periods. Significant estimates, judgments, and assumptions in these consolidated financial statements include: allocating variable consideration for revenue recognition; the amortization period for deferred commissions; the </p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2. Summary of significant accounting policies&#160;(continued)</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">allowance for credit losses; a determination of the deferred tax asset valuation allowance and the valuation of our common stock used to determine stock-based compensation expense prior to our IPO. Because of the use of estimates inherent in the financial reporting process and given the additional or unforeseen effects from the COVID-19 pandemic, actual results could differ from those estimates, and such differences could be material to our consolidated financial statements.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">COVID-19, declared a global pandemic by the World Health Organization on March 11, 2020, has caused disruption to the economies and communities of the United States and our target international markets. In the interest of public health, many governments closed physical stores and places of business deemed non-essential. This precipitated a significant shift in shopping behavior from offline to online. Our business has benefited from this shift, both in accelerated sales growth for our existing customers&#8217; stores, and in our sales of new store subscriptions to customers. Nevertheless, we do not have certainty that those trends will continue; the COVID-19 pandemic and the uncertainty it has created in the global economy could materially adversely affect our business, financial condition, and results of operations.</p>
CY2021Q1 bigc Amortization Of Deferred Sales Commissions Estimated Period
AmortizationOfDeferredSalesCommissionsEstimatedPeriod
P4Y
CY2021Q1 bigc Impairment Of Deferred Commissions
ImpairmentOfDeferredCommissions
0
CY2020Q1 bigc Impairment Of Deferred Commissions
ImpairmentOfDeferredCommissions
0
CY2020 bigc Impairment Of Deferred Commissions
ImpairmentOfDeferredCommissions
0
CY2021Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2013-02-28
CY2021Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
7500000
CY2020Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
7500000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1992000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
358000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2360000
CY2021Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
5700000
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
92900000
CY2021Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.56
CY2021Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2021Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Explanation
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
We expect to recognize approximately 56% of the remaining performance obligations as revenue in the following 12-month periods, and the remaining balance in the periods thereafter.
CY2021Q1 bigc Deferred Sales Commissions
DeferredSalesCommissions
1500000
CY2020Q1 bigc Deferred Sales Commissions
DeferredSalesCommissions
700000
CY2021Q1 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
700000
CY2020Q1 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
500000
CY2021Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
190176000
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
21087000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20607000
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14191000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13485000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
700000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
900000
CY2021Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2020Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2021Q1 bigc Lease Operating Lease Expiration Year
LeaseOperatingLeaseExpirationYear
2028
CY2021Q1 bigc Operating And Short Term Rent Expense
OperatingAndShortTermRentExpense
900000
CY2020Q1 bigc Operating And Short Term Rent Expense
OperatingAndShortTermRentExpense
800000
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
972000
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
871000
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y10M24D
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y8M12D
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0546
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0552
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2971000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3081000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2504000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2255000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2011000
CY2021Q1 bigc Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
4923000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
17745000
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2671000
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
15074000
CY2021Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
759000
CY2020Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
635000
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12415000
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5520000
CY2021Q1 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
3310000
CY2020Q1 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
3241000
CY2020Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9396000
CY2020Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
900000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
225346
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
59.56
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.562
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0109
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5171000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1026000
CY2021Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0042
CY2021Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
0
CY2021Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9359000
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
49850000

Files In Submission

Name View Source Status
R43.htm Edgar Link pending
0001564590-21-026757-index-headers.html Edgar Link pending
0001564590-21-026757-index.html Edgar Link pending
0001564590-21-026757.txt Edgar Link pending
0001564590-21-026757-xbrl.zip Edgar Link pending
bigc-10q_20210331.htm Edgar Link pending
bigc-20210331.xml Edgar Link completed
bigc-20210331.xsd Edgar Link pending
bigc-20210331_cal.xml Edgar Link unprocessable
bigc-20210331_def.xml Edgar Link unprocessable
bigc-20210331_lab.xml Edgar Link unprocessable
bigc-20210331_pre.xml Edgar Link unprocessable
bigc-ex311_7.htm Edgar Link pending
bigc-ex312_8.htm Edgar Link pending
bigc-ex321_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending